(Q43040234)

12 November 2017

title

Recombinant antibody Fab against the hypervariable region 1 of hepatitis C virus blocks the virus adsorption to susceptible cells in vitro (English)

1 reference

12 November 2017

1 reference

Yi-Hua Zhou

1

1 reference

12 November 2017

Masataka Takekoshi

2

1 reference

12 November 2017

Fumiko Maeda

3

1 reference

12 November 2017

Seiji Ihara

4

1 reference

12 November 2017

Mariko Esumi

5

1 reference

12 November 2017

publication date

1 October 2002

1 reference

12 November 2017

1 reference

12 November 2017

volume

56

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

51-59

1 reference

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

'Touchdown' PCR to circumvent spurious priming during gene amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Multimeric humanized varicella-zoster virus antibody fragments to gH neutralize virus while monomeric fragments do not.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Prevention of hepatitis C virus infection in a chimpanzee by vaccination and epitope mapping of antiserum directed against hypervariable region 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Hypervariable regions in the putative glycoprotein of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

By-passing immunization: building high affinity human antibodies by chain shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Human monoclonal anti-HCMV neutralizing antibody from phage display libraries.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900092-X

7 January 2021

10.1016/S0166-3542(02)00092-X

Identifiers

DOI

1 reference

12 November 2017

1 reference